ZNF746 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.741900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.346800E-01
Normal-vs-Stage2
3.655800E-02
Normal-vs-Stage3
4.929900E-02
Normal-vs-Stage4
3.006200E-01
Stage1-vs-Stage2
3.911400E-01
Stage1-vs-Stage3
1.590840E-01
Stage1-vs-Stage4
5.662400E-01
Stage2-vs-Stage3
1.120800E-01
Stage2-vs-Stage4
9.360000E-01
Stage3-vs-Stage4
3.501200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.226000E-02
Normal-vs-AfricanAmerican
1.929380E-01
Normal-vs-Asian
1.163430E-01
Caucasian-vs-AfricanAmerican
6.454600E-01
Caucasian-vs-Asian
7.465000E-01
AfricanAmerican-vs-Asian
5.364400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.976200E-02
Normal-vs-Female
8.728100E-02
Male-vs-Female
8.025400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.215200E-01
Normal-vs-Age(41-60Yrs)
1.566560E-01
Normal-vs-Age(61-80Yrs)
4.534300E-02
Normal-vs-Age(81-100Yrs)
5.050200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.223800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.805600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.985200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.093820E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.942230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.834800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.817970E-02
Normal-vs-Daily Drinker
7.935900E-02
Normal-vs-Weekly Drinker
3.361800E-01
Normal-vs-Occasional Drinker
8.074100E-02
Normal-vs-Social Drinker
3.862800E-01
Non Drinker-vs-Daily Drinker
3.350800E-01
Non Drinker-vs-Weekly Drinker
8.294500E-02
Non Drinker-vs-Occasional Drinker
2.354600E-01
Non Drinker-vs-Social Drinker
1.026040E-02
Daily Drinker-vs-Weekly Drinker
3.762600E-01
Daily Drinker-vs-Occasional Drinker
8.276000E-01
Daily Drinker-vs-Social Drinker
1.117600E-01
Weekly Drinker-vs-Occasional Drinker
4.827200E-01
Weekly Drinker-vs-Social Drinker
6.291600E-01
Occasional Drinker-vs-Social Drinker
1.601610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.477600E-01
Normal-vs-Grade 2
9.853800E-01
Normal-vs-Grade 3
9.929000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.185000E-01
Grade 1-vs-Grade 3
5.281200E-01
Grade 1-vs-Grade 4
9.477600E-01
Grade 2-vs-Grade 3
5.531400E-01
Grade 2-vs-Grade 4
9.853800E-01
Grade 3-vs-Grade 4
9.929000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.332400E-02
Normal-vs-NonDiabetic
1.202960E-01
Diabetic-vs-NonDiabetic
1.092420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.436400E-02
Normal-vs-NoPancreatitis
1.052580E-01
Pancreatitis-vs-NoPancreatitis
6.911000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.124550E-01
Normal-vs-N1
4.409600E-02
N0-vs-N1
3.993400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.064000E-02
Normal-vs-TP53-NonMutant
2.839400E-01
TP53-Mutant-vs-TP53-NonMutant
1.774010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
